date,title,source
Nov-01-18,Kiniksa Reports Third Quarter 2018 Financial Results and Pipeline Progress,GlobeNewswire
Nov-15-18,"Detailed Research: Economic Perspectives on Knight-Swift Transportation, Benitec Biopharma, Eastern, Kiniksa Pharmaceuticals, Qualstar, and Nomura Holdings Inc ADR  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Dec-06-18,Kiniksa Provides Update on U.S. FDA Review of Investigational New Drug Application for Mavrilimumab in Giant Cell Arteritis,GlobeNewswire
Dec-11-18,Kiniksa Announces Rilonacept Interim Phase 2 Clinical Data and Initiates Pivotal Phase 3 Clinical Trial,GlobeNewswire
Dec-17-18,Kiniksa Pharmaceuticals to Present at 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Dec-27-18,5 Best-Performing IPOs of 2018,Zacks
Jan-03-19,Kiniksa Announces Active U.S. Investigational New Drug Application for Mavrilimumab,GlobeNewswire
Jan-28-19,"Kiniksa Pharmaceuticals, Ltd. Announces Proposed Public Offering and Concurrent Private Placement",GlobeNewswire
Jan-29-19,"The Daily Biotech Pulse: Big Pharma Earnings, Kiniksa Offering, FDA Decision Day For Aquestive",Benzinga
Jan-31-19,"Kiniksa Pharmaceuticals, Ltd. Announces Pricing of Public Offering",GlobeNewswire
Feb-26-19,Kiniksa Pharmaceuticals to Present at the Barclays Global Healthcare Conference,GlobeNewswire
Feb-28-19,Kiniksa Pharmaceuticals to Present at the Cowen and Company 39th Annual Healthcare Conference,GlobeNewswire
Mar-07-19,Kiniksa Reports Fourth Quarter and Full-Year 2018 Financial Results and Highlights Recent Corporate and Pipeline Activity,GlobeNewswire
Mar-18-19,Kiniksa Presents Rilonacept Interim Phase 2 Clinical Data Poster at the American College of Cardiologys 68th Annual Scientific Session,GlobeNewswire
Apr-08-19,Kiniksa to Present KPL-404 Preclinical Data at the Keystone Symposia on Antibodies as Drugs,GlobeNewswire
